FDA. Guidance For Industry. Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects.
I. INTRODUCTION
This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance.
This guidance provides an overview of the responsibilities of a person who conducts a clinical investigation of a drug, biological product, or medical device (an investigator as defined in 21 CFR 312.3(b) and 21 CFR 812.3(i)). The goal of this guidance is to help investigators better meet their responsibilities with respect to protecting human subjects and ensuring the integrity of the data from clinical investigations. This guidance is intended to clarify for investigators and sponsors FDA’s expectations concerning the investigator’s responsibility (1) to supervise a clinical study in which some study tasks are delegated to employees or colleagues of the investigator or other third parties and (2) to protect the rights, safety, and welfare of study subjects.
FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.
Authors:
Center for Drug Evaluation and Research
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research
OCTOBER 2009
Clinical Research News
Kommende kliniske studier
-
Intuitive SurgicalHar ikke rekruttert ennå
-
Bristol-Myers SquibbHar ikke rekruttert ennå
-
University of Alabama at BirminghamHar ikke rekruttert ennåSpinal Cord DisordersForente stater
-
Medical University of ViennaHar ikke rekruttert ennåVaskulær tilgang | Vaskulær tilgangskomplikasjon | Dialysekateterinfeksjoner | Hemodialyse | Hemodialysekomplikasjon | Dysfunksjon i dialysetilgang | ESRD (sluttstadium nyresykdom) | DialysekateterØsterrike
-
NYU Langone HealthNational Cancer Institute (NCI)Har ikke rekruttert ennåProstatakreftForente stater
-
M.D. Anderson Cancer CenterHar ikke rekruttert ennåKutant angiosarkomForente stater
-
Helwan UniversityHar ikke rekruttert ennå
-
Prevention Strategies, LLCNational Institute on Drug Abuse (NIDA); NORC at the University of ChicagoHar ikke rekruttert ennåAlkoholrelaterte lidelser | Tobakksbruksforstyrrelse | Marihuana bruk | Stoffrelaterte lidelser
-
Second Affiliated Hospital of Nanchang UniversityBeijing Pearl Biotechnology Limited Liability CompanyRekruttering
-
Ming LiuHar ikke rekruttert ennåGastrisk adenokarsinom | Gastroøsofageal Junction AdenocarcinomaKina
-
The First Affiliated Hospital of Soochow UniversityHar ikke rekruttert ennåGastriske submukosale svulster
-
Peking University First HospitalPeking University Shenzhen HospitalHar ikke rekruttert ennåEldre pasienter | Kreftkirurgi | Målrettet temperaturstyring | Hypotermi, utilsiktet | Forsinket nevrokognitiv utvinningKina
Clinical Research Jobs
-
United Kingdom - London
-
Germany - Hessen
-
United States - North Carolina - Durham
-
Poland - Krakow
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China
